Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. suis eradication for gastric MALT lymphoma and intractable peptic ulcer
jRCTs031200105Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Oct 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial in Gastric Marginal Zone B-Cell Lymphoma Of Mucosa-Associated Lymphoid Tissue, Peptic ulcer disease (PUD), gastric ulcer and 3 more, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Success or failure of NHPH (including H. suis) eradication and clinical efficacy. Started Oct 2020; status: active, not recruiting.
02
Conditions
Gastric Marginal Zone B-Cell Lymphoma Of Mucosa-Associated Lymphoid TissuePeptic ulcer disease (PUD)gastric ulcerduodenal ulcernon-Helicobacter pylori Helicobacter infection
Beyond the preview
Go deeper on jRCTs031200105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200105.